Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Estrogen receptor (ER)-negative cancers have a poor prognosis, and few targeted therapies are available for their treatment. Our previous analyses have identified potential kinase targets critical for the growth of ER-negative, progesterone receptor (PR)-negative and HER2-negative, or “triple-negati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Mazumdar, Abhijit, Poage, Graham M., Shepherd, Jonathan, Tsimelzon, Anna, Hartman, Zachary C., Den Hollander, Petra, Hill, Jamal, Zhang, Yun, Chang, Jenny, Hilsenbeck, Susan G., Fuqua, Suzanne, Kent Osborne, C., Mills, Gordon B., Brown, Powel H.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Preclinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963453/
https://ncbi.nlm.nih.gov/pubmed/27393618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3892-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados